Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2016-06-01 13:30:24 |
Versijas komentārs | |
Teksts |
Olainfarm will
hold First Quarter 2016 Investor Conference Webinar
AS „Olainfarm”
invites shareholders, investors, mass media representatives and
other stakeholders to join its investor conference webinar
scheduled on June 8, 2016 at 16:00 (EET).
To join the webinar please follow
the instructions below. Webinar will be
hosted by the Member of the Management Board Salvis Lapiņš. The
presentation will be held in English. During the webinar
Salvis Lapiņš will inform about AS “Olainfarm” latest activities,
provide more detailed information about the recent acquisition -
company “Tonus Elast” and analyze the financial results of the
first quarter 2016. After the
presentation investors are welcome to ask questions. Due to
the limited webinar time, please send in your questions in advance
till June 7 to e-mail: ieva.unda@nasdaq.com or Investors’ portal
naudaslietas.lv.
What is
webinar? How to join the
webinar? To join the webinar, we invite you
to register via
ej.uz/OLF_Q1_2016. You will be provided with the
webinar link and instructions to join webinar successfully. When
joining the webinar for the first time, you will be asked to
download the system application on your computer which will take
only few seconds. For more
information on webinar service please visit:
http://www.nasdaqbaltic.com/en/products-services/webinars-3/
JSC Olainfarm is one of the
biggest pharmaceutical companies in Latvia with more than 40 years
of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 35 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia. Information
prepared by: |
Pielikumi |
|